Stephen Eeden to Treatment Outcome
This is a "connection" page, showing publications Stephen Eeden has written about Treatment Outcome.
Connection Strength
0.371
-
A Biopsy-based 17-gene Genomic Prostate Score as a Predictor of Metastases and Prostate Cancer Death in Surgically Treated Men with Clinically Localized Disease. Eur Urol. 2018 01; 73(1):129-138.
Score: 0.057
-
5-Alpha Reductase Inhibitors and the Risk of Prostate Cancer Mortality in Men Treated for Benign Prostatic Hyperplasia. Mayo Clin Proc. 2016 Dec; 91(12):1717-1726.
Score: 0.053
-
Use of androgen deprivation therapy as salvage treatment after primary therapy for clinically localized prostate cancer. World J Urol. 2016 Dec; 34(12):1611-1619.
Score: 0.051
-
Effectiveness of primary androgen-deprivation therapy for clinically localized prostate cancer. J Clin Oncol. 2014 May 01; 32(13):1324-30.
Score: 0.045
-
Oral magnesium oxide prophylaxis of frequent migrainous headache in children: a randomized, double-blind, placebo-controlled trial. Headache. 2003 Jun; 43(6):601-10.
Score: 0.042
-
Complementary and alternative medicine use, patient-reported outcomes, and treatment satisfaction among men with localized prostate cancer. Urology. 2012 May; 79(5):1034-41.
Score: 0.039
-
Unanticipated and underappreciated outcomes during management of local stage prostate cancer: a prospective survey. J Urol. 2010 Jul; 184(1):120-5.
Score: 0.034
-
Ectopic pregnancy rate and treatment utilization in a large managed care organization. Obstet Gynecol. 2005 May; 105(5 Pt 1):1052-7.
Score: 0.024
-
Quality of life, health care utilization, and costs among women undergoing hysterectomy in a managed-care setting. Am J Obstet Gynecol. 1998 Jan; 178(1 Pt 1):91-100.
Score: 0.014
-
A conditional analysis for two-treatment multiple-period crossover designs with binomial or poisson outcomes and subjects who drop out. Stat Med. 1993 May 15; 12(9):825-34.
Score: 0.010